Taken together, these results demonstrate that LINC01089 suppressed NSCLC tumorigenesis and progression by inhibiting the miR-27a–SFRP1-Wnt/β-catenin–EMT pathway. Here, LINC01089 is linked to non-small cell lung carcinoma.